Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
41
LOAN Quote, Financials, Valuation and Earnings
Last price:
$4.60
Seasonality move
:
-3.56%
Day range:
$4.55 - $4.67
52-week range:
$4.29 - $6.05
Dividend yield:
9.89%
P/E ratio:
10.05x
P/S ratio:
5.89x
P/B ratio:
1.23x
Volume:
76.1K
Avg. volume:
37.8K
1-year change:
-16.97%
Market cap:
$53.2M
Revenue:
$9.7M
EPS (TTM):
$0.46
Analysts' Opinion
-
Consensus RatingManhattan Bridge Capital, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Manhattan Bridge Capital, Inc. has an estimated upside of 50.54% from its current price of $4.65.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $4.65.
Fair Value
-
According to the consensus of 1 analyst, Manhattan Bridge Capital, Inc. has 50.54% upside to fair value with a price target of -- per share.
LOAN vs. S&P 500
-
Over the past 5 trading days, Manhattan Bridge Capital, Inc. has underperformed the S&P 500 by -2.55% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Manhattan Bridge Capital, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Manhattan Bridge Capital, Inc. revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Manhattan Bridge Capital, Inc. reported revenues of $2M.
Earnings Growth
-
Manhattan Bridge Capital, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Manhattan Bridge Capital, Inc. reported earnings per share of $0.11.
Enterprise value:
68.2M
EV / Invested capital:
--
Price / LTM sales:
5.89x
EV / EBIT:
9.52x
EV / Revenue:
7.56x
PEG ratio (5yr expected):
5.05x
EV / Free cash flow:
14.41x
Price / Operating cash flow:
11.24x
Enterprise value / EBITDA:
9.51x
Gross Profit (TTM):
$9M
Return On Assets:
7.97%
Net Income Margin (TTM):
58.68%
Return On Equity:
12.22%
Return On Invested Capital:
8.19%
Operating Margin:
79.56%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $9.5M | $9.9M | $9M | $2.3M | $2M | |
| Gross Profit | $9.5M | $9.9M | $9M | $2.3M | $2M | |
| Operating Income | $7.8M | $8.1M | $7.2M | $1.9M | $1.6M | |
| EBITDA | $7.8M | $8.1M | $7.2M | $1.9M | $1.6M | |
| Diluted EPS | $0.46 | $0.49 | $0.46 | $0.12 | $0.11 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1M | $1.7M | $1.5M | $1.7M | $1.8M | |
| Total Assets | $55.1M | $74.8M | $72.6M | $70.7M | $60M | |
| Current Liabilities | $529.5K | $2.3M | $2.2M | $2.1M | $1.5M | |
| Total Liabilities | $10M | $31.7M | $29.7M | $27.4M | $16.7M | |
| Total Equity | $45.1M | $43.1M | $42.9M | $43.3M | $43.3M | |
| Total Debt | $9.5M | $29.4M | $27.5M | $25.3M | $15.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $5.2M | $5.1M | $4.7M | $1.2M | $1.4M | |
| Cash From Investing | $1.9M | $2.5M | $10.7M | -$1.7M | $7.4M | |
| Cash From Financing | -$7.6M | -$7.6M | -$15.4M | $509.3K | -$8.8M | |
| Free Cash Flow | $5.2M | $5.1M | $4.7M | $1.2M | $1.4M | |
LOAN
Sector
Market Cap
$53.2M
$554M
Price % of 52-Week High
76.86%
90.96%
Dividend Yield
9.89%
1.58%
Shareholder Yield
11.01%
3.08%
1-Year Price Total Return
-16.97%
6.77%
Beta (5-Year)
0.252
0.463
Dividend yield:
9.89%
Annualized payout:
$0.46
Payout ratio:
109.42%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$4.84
200-day SMA
Sell
Level
$5.23
Bollinger Bands (100)
Sell
Level
4.78 - 5.44
Chaikin Money Flow
Sell
Level
-941.6K
20-day SMA
Sell
Level
$4.81
Relative Strength Index (RSI14)
Sell
Level
38.45
ADX Line
Sell
Level
15.97
Williams %R
Neutral
Level
-78.2326
50-day SMA
Sell
Level
$4.83
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Sell
Level
-1M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.0517)
Buy
CA Score
(Annual)
Level (0.5267)
Buy
Beneish M-Score
(Annual)
Level (-3.1723)
Sell
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.4273)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Manhattan Bridge Capital, Inc. engages in originating, servicing, and managing a portfolio of first mortgage loans. It offers short-term, secured, non-banking loans to real estate investors to fund their acquisition and construction of properties located in the New York Metropolitan area. The company was founded by Assaf N. Ran in 1989 and is headquartered in Great Neck, NY.
Stock Forecast FAQ
In the current month, LOAN has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The LOAN average analyst price target in the past 3 months is --.
-
Where Will Manhattan Bridge Capital, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Manhattan Bridge Capital, Inc. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Manhattan Bridge Capital, Inc.?
Analysts are divided on their view about Manhattan Bridge Capital, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Manhattan Bridge Capital, Inc. is a Sell and believe this share price will drop from its current level to --.
-
What Is Manhattan Bridge Capital, Inc.'s Price Target?
The price target for Manhattan Bridge Capital, Inc. over the next 1-year time period is forecast to be -- according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is LOAN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Manhattan Bridge Capital, Inc. is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of LOAN?
You can purchase shares of Manhattan Bridge Capital, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Manhattan Bridge Capital, Inc. shares.
-
What Is The Manhattan Bridge Capital, Inc. Share Price Today?
Manhattan Bridge Capital, Inc. was last trading at $4.60 per share. This represents the most recent stock quote for Manhattan Bridge Capital, Inc.. Yesterday, Manhattan Bridge Capital, Inc. closed at $4.65 per share.
-
How To Buy Manhattan Bridge Capital, Inc. Stock Online?
In order to purchase Manhattan Bridge Capital, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get LOAN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LOAN
Sector
P/E ratio
10.05x
12.15x
PEG ratio
5.05x
0.31x
P/B ratio
1.23x
1.10x
Price / LTM sales
5.89x
1.82x
Growth Metrics
LOAN
Sector
Revenue growth
-12%
5.54%
Earnings growth
-14.06%
14.85%
Revenue (5-year growth)
5.71%
8.84%
Earnings forecast
$0.10
$0.64
Profitability
LOAN
Sector
Profitability FY 2024
$9.7M
--
Return on invested capital
8.19%
5.01%
Return on assets
7.97%
1.01%
Return on equity
12.22%
9.67%
Earnings Date
Last Earnings Date
Mar
11
Next Earnings Date
Jan
2
Estimated Next Earnings Date
Apr
3
Balance Sheet
LOAN
Sector
Total cash
$200.3K
$430.8M
Short term investments
--
$211.1M
Total assets
$67.9M
$3.1B
Long term debt
$15.2M
$79M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.11% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.83% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 9.63% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
